Research Article
Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial
Table 3
Secondary endpoints: changes in the functional and symptom scales of EORTO-QLQ-BR23, lymphocytes, and body weight in the intent-to-treat population.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
THL-P: Tien Hsien liquid practical; EORTO-QLQ-BR23: European Organization for Research and Treatment of Breast Cancer-Specific Quality of Life Questionnaire. * versus placebo (Mann-Whitney U testa or independent, two-sample testb). † versus baseline (Wilcoxon signed ranks testa or paired Student’s t-testb). Values are presented as median (interquartile)a and mean ± standard deviationb. |